Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: A non-genomic anti-inflammatory switch

European Journal of Pharmacology

Volumn 583, Issue 2-3, 2008, Pages 322-339

  Malcher Lopes, Renato ^a   Franco, Alier ^c   Tasker, Jeffrey G ^b,c  

^a EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

^b TULANE UNIVERSITY   (United States)

^c Tulane University   (United States)

Author keywords

Anti inflammatory; Arachidonic acid; Endocannabinoid; Glucocorticoid; Hypothalamus; Leptin

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; ENDOCANNABINOID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LEPTIN; MEMBRANE LIPID;

ANTERIOR HYPOTHALAMUS; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; BRAIN METABOLISM; ENERGY METABOLISM; ENZYME SYNTHESIS; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; INSULIN RESISTANCE; METABOLIC REGULATION; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; ELECTROPHYSIOLOGY; ENDOCANNABINOIDS; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; SIGNAL TRANSDUCTION;

EID: 40849117877     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.12.033     Document Type: Review

References (233)

1. Ahn N.G., Seger R., Bratlien R.L., Diltz C.D., Tonks N.K., and Krebs E.G. Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J. Biol. Chem. 266 (1991) 4220-4227
2. Alger B.E., Pitler T.A., Wagner J.J., Martin L.A., Morishita W., Kirov S.A., and Lenz R.A. Retrograde signalling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J. Physiol. 496 Pt 1 (1996) 197-209
3. Allison J.P., and Havran W.L. The immunobiology of T cells with invariant gamma delta antigen receptors. Annu. Rev. Immunol. 9 (1991) 679-705
4. Amarneh B.A., and Simpson E.R. Detection of aromatase cytochrome P450, 17 alpha-hydroxylase cytochrome P450 and NADPH:P450 reductase on the surface of cells in which they are expressed. Mol. Cell. Endocrinol. 119 (1996) 69-74
5. Ameri A. The effects of cannabinoids on the brain. Prog. Neurobiol. 58 (1999) 315-348
6. *. Annu. Rev. Immunol. 18 (2000) 309-345
7. Avitsur R., Pollak Y., and Yirmiya R. Administration of interleukin-1 into the hypothalamic paraventricular nucleus induces febrile and behavioral effects. Neuroimmunomodulation 4 (1997) 258-265
8. Bailey J.M. New mechanisms for effects of anti-inflammatory glucocorticoids. Biofactors 3 (1991) 97-102
9. Bamberger C.M., Schulte H.M., and Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17 (1996) 245-261
10. Barna I., Zelena D., Arszovszki A.C., and Ledent C. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice. Life Sci. 75 (2004) 2959-2970
11. Barnes P.J. Inhaled glucocorticoids for asthma. N. Engl. J. Med 332 (1995) 868-875
12. Barnes P.J., and Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14 (1993) 436-441
13. Beato M., Chavez S., and Truss M. Transcriptional regulation by steroid hormones. Steroids 61 (1996) 240-251
14. Beck C.A., Estes P.A., Bona B.J., Muro-Cacho C.A., Nordeen S.K., and Edwards D.P. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology 133 (1993) 728-740
15. Beltramo M., and Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. NeuroReport 11 (2000) 1231-1235
16. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., and Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277 (1997) 1094-1097
17. Benamar K., Yondorf M., Meissler J.J., Geller E.B., Tallarida R.J., Eisenstein T.K., and Adler M.W. A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide. J. Pharmacol. Exp. Ther. 320 (2007) 1127-1133
18. Bisogno T., MacCarrone M., De Petrocellis L., Jarrahian A., Finazzi-Agro A., Hillard C., and Di Marzo V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem. 268 (2001) 1982-1989
19. Bisogno T., Melck D., De Petrocellis L., and Di Marzo V. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J. Neurochem. 72 (1999) 2113-2119
20. Boudaba C., Szabo K., and Tasker J.G. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J. Neurosci. 16 (1996) 7151-7160
21. Boumpas D.T., Paliogianni F., Anastassiou E.D., and Balow J.E. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin. Exp. Rheumatol. 9 (1991) 413-423
22. Breivogel C.S., and Childers S.R. The functional neuroanatomy of brain cannabinoid receptors. Neurobiol. Dis. 5 (1998) 417-431
23. Brush F.R., Dallman M., Jones M.T., and Tiptaft E. Proceedings: Corticosteroid Feedback at the Pituitary Level. J. Endocrinol. vol. 61 (1974) LXIV-LXV
24. Buren J., Liu H.X., Jensen J., and Eriksson J.W. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur. J. Endocrinol. 146 (2002) 419-429
25. Cadas H., Gaillet S., Beltramo M., Venance L., and Piomelli D. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci. 16 (1996) 3934-3942
26. 2 from bee venom: apparent activation by intervesicle exchange of phospholipids. Biochemistry 36 (1997) 3882-3893
27. Calder P.C. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33 (2005) 423-427
28. Calignano A., La Rana G., Giuffrida A., and Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 394 (1998) 277-281
29. Calignano A., La Rana G., and Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol. 419 (2001) 191-198
30. Cambronero J.C., Rivas F.J., Borrell J., and Guaza C. Interleukin-1-beta induces pituitary adrenocorticotropin secretion: evidence for glucocorticoid modulation. Neuroendocrinology 55 (1992) 648-654
31. Carrier E.J., Patel S., and Hillard C.J. Endocannabinoids in neuroimmunology and stress. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 657-665
32. Castelli M.P., Piras A.P., Melis T., Succu S., Sanna F., Melis M.R., Collu S., Grazia Ennas M., Diaz G., Mackie K., and Argiolas A. Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies. Neuroscience 147 (2007) 197-206
33. Cato A.C., and Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18 (1996) 371-378
34. Chan T.O., Rittenhouse S.E., and Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68 (1999) 965-1014
35. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., and Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14 (1994) 4902-4911
36. Chen P., Hu S., Yao J., Moore S.A., Spector A.A., and Fang X. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvasc. Res. 69 (2005) 28-35
37. Chivers J.E., Cambridge L.M., Catley M.C., Mak J.C., Donnelly L.E., Barnes P.J., and Newton R. Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E release. Eur. J. Biochem. 271 (2004) 4042-4052
38. Cifone M.G., Migliorati G., Parroni R., Marchetti C., Millimaggi D., Santoni A., and Riccardi C. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93 (1999) 2282-2296
39. 2 stimulatory peptide melittin. J. Biol. Chem. 262 (1987) 4402-4406
40. Cohen J.J., and Duke R.C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132 (1984) 38-42
41. Cooke M.P., and Perlmutter R.M. Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol. 1 (1989) 66-74
42. Correa F., Mestre L., Molina-Holgado E., Arevalo-Martin A., Docagne F., Romero E., Molina-Holgado F., Borrell J., and Guaza C. The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation. Mini Rev. Med. Chem. 5 (2005) 671-675
43. Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grubler Y., Stalla J., Pasquali R., Lutz B., Stalla G.K., and Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 148 (2007) 1574-1581
44. Croxtall J.D., Choudhury Q., and Flower R.J. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br. J. Pharmacol. 130 (2000) 289-298
45. 2 phosphorylation. Biochem. Pharmacol. 52 (1996) 351-356
46. 2 activity. Biochem. Pharmacol. 50 (1995) 465-474
47. Croxtall J.D., van Hal P.T., Choudhury Q., Gilroy D.W., and Flower R.J. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br. J. Pharmacol. 135 (2002) 511-519
48. Czech M.P., and Corvera S. Signaling mechanisms that regulate glucose transport. J. Biol. Chem. 274 (1999) 1865-1868
49. Dallman M.F., and Jones M.T. Corticosteroid feedback control of ACTH secretion: effect of stress-induced corticosterone ssecretion on subsequent stress responses in the rat. Endocrinology 92 (1973) 1367-1375
50. Davis M.I., Ronesi J., and Lovinger D.M. A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. J. Biol. Chem. 278 (2003) 48973-48980
51. Dayanithi G., and Antoni F.A. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology 125 (1989) 308-313
52. De Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 (1998) 269-301
53. de Vries-Smits A.M., Burgering B.M., Leevers S.J., Marshall C.J., and Bos J.L. Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature 357 (1992) 602-604
54. DeGeorge J.J., Noronha J.G., Bell J., Robinson P., and Rapoport S.I. Intravenous injection of [1-14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J. Neurosci. Res. 24 (1989) 413-423
55. Denny M.F., Kaufman H.C., Chan A.C., and Straus D.B. The lck SH3 domain is required for activation of the mitogen-activated protein kinase pathway but not the initiation of T-cell antigen receptor signaling. J. Biol. Chem. 274 (1999) 5146-5152
56. Denny M.F., Patai B., and Straus D.B. Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn. Mol Cell Biol 20 (2000) 1426-1435
57. Derkinderen P., Ledent C., Parmentier M., and Girault J.A. Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J. Neurochem. 77 (2001) 957-960
58. Derkinderen P., Valjent E., Toutant M., Corvol J.C., Enslen H., Ledent C., Trzaskos J., Caboche J., and Girault J.A. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23 (2003) 2371-2382
59. Devane W.A., and Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 6698-6701
60. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
61. Di Marzo V. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta 1392 (1998) 153-175
62. Di Marzo V. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. Life Sci. 65 (1999) 645-655
63. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J.A., and Kunos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264 (1999) 258-267
64. Di Marzo V., De Petrocellis L., Bisogno T., and Melck D. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. Lipids 34 (1999) S319-S325 Suppl.
65. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A., and Bisogno T. Anandamide receptors. Prostaglandins Leukot. Essent. Fat. Acids 66 (2002) 377-391
66. Di Marzo V., De Petrocellis L., Sugiura T., and Waku K. Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Biochem. Biophys. Res. Commun. 227 (1996) 281-288
67. Di Marzo V., and Deutsch D.G. Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol. Dis. 5 (1998) 386-404
68. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (1994) 686-691
69. Di S., Malcher-Lopes R., Halmos K.C., and Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 23 (2003) 4850-4857
70. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., and Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 146 (2005) 4292-4301
71. Doherty N.S. Inhibition of arachidonic acid release as the mechanism by which glucocorticoids inhibit endotoxin-induced diarrhoea. Br. J. Pharmacol. 73 (1981) 549-554
72. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12 (1998) 1063-1073
73. Ehrlich L.I., Ebert P.J., Krummel M.F., Weiss A., and Davis M.M. Dynamics of p56lck translocation to the T cell immunological synapse following agonist and antagonist stimulation. Immunity 17 (2002) 809-822
74. Eljaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., and Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49 (2006) 67-79
75. 2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197 (1993) 292-297
76. Epps D.E., Natarajan V., Schmid P.C., and Schmid H.O. Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim. Biophys. Acta 618 (1980) 420-430
77. Epps D.E., Schmid P.C., Natarajan V., and Schmid H.H. N-acylethanolamine accumulation in infarcted myocardium. Biochem. Biophys. Res. Commun. 90 (1979) 628-633
78. Felder C.C., Joyce K.E., Briley E.M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A.L., and Mitchell R.L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48 (1995) 443-450
79. Felder C.C., Nielsen A., Briley E.M., Palkovits M., Priller J., Axelrod J., Nguyen D.N., Richardson J.M., Riggin R.M., Koppel G.A., Paul S.M., and Becker G.W. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 393 (1996) 231-235
80. Ferri C.C., and Ferguson A.V. Interleukin-1 beta depolarizes paraventricular nucleus parvocellular neurones. J. Neuroendocrinol. 15 (2003) 126-133
81. Ferri C.C., and Ferguson A.V. Prostaglandin E2 mediates cellular effects of interleukin-1beta on parvocellular neurones in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol 17 (2005) 498-508
82. Ferri C.C., Yuill E.A., and Ferguson A.V. Interleukin-1beta depolarizes magnocellular neurons in the paraventricular nucleus of the hypothalamus through prostaglandin-mediated activation of a non selective cationic conductance. Regul. Pept. 129 (2005) 63-71
83. ffrench-Mullen J.M. Cortisol inhibition of calcium currents in guinea pig hippocampal CA1 neurons via G-protein-coupled activation of protein kinase C. J. Neurosci. 15 (1995) 903-911
84. Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann. N. Y. Acad. Sci. 1024 (2004) 124-137
85. Fremeau Jr. R.T., Lundblad J.R., Pritchett D.B., Wilcox J.N., and Roberts J.L. Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei. Science 234 (1986) 1265-1269
86. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
87. Fryer C.J., Kinyamu H.K., Rogatsky I., Garabedian M.J., and Archer T.K. Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J. Biol. Chem. 275 (2000) 17771-17777
88. Funder J.W. Glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 43 (1992) 389-394
89. Funder J.W. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu. Rev. Med. 48 (1997) 231-240
90. Fuxe K., Harfstrand A., Agnati L.F., Yu Z.Y., Cintra A., Wikstrom A.C., Okret S., Cantoni E., and Gustafsson J.A. Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor. Neurosci. Lett. 60 (1985) 1-6
91. Fuxe K., Wikstrom A.C., Okret S., Agnati L.F., Harfstrand A., Yu Z.Y., Granholm L., Zoli M., Vale W., and Gustafsson J.A. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117 (1985) 1803-1812
92. Gonzalez S., Manzanares J., Berrendero F., Wenger T., Corchero J., Bisogno T., Romero J., Fuentes J.A., Di Marzo V., Ramos J.A., and Fernandez-Ruiz J. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology 70 (1999) 137-145
93. Graber R., and Losa G.A. Changes in the activities of signal transduction and transport membrane enzymes in CEM lymphoblastoid cells by glucocorticoid-induced apoptosis. Anal. Cell. Pathol. 8 (1995) 159-175
94. Groner B., Hynes N.E., Rahmsdorf U., and Ponta H. Transcription initiation of transfected mouse mammary tumor virus LTR DNA is regulated by glucocorticoid hormones. Nucleic Acids Res. 11 (1983) 4713-4725
95. Han H.J., Lee Y.H., and Park S.H. Estradiol-17beta-BSA stimulates Ca(2+) uptake through nongenomic pathways in primary rabbit kidney proximal tubule cells: involvement of cAMP and PKC. J. Cell Physiol. 183 (2000) 37-44
96. Han J.Z., Lin W., and Chen Y.Z. Inhibition of ATP-induced calcium influx in HT4 cells by glucocorticoids: involvement of protein kinase A. Acta Pharmacol. Sin. 26 (2005) 199-204
97. Hansen H.S., Lauritzen L., Strand A.M., Moesgaard B., and Frandsen A. Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. Biochim. Biophys. Acta 1258 (1995) 303-308
98. Hansen H.S., Moesgaard B., Hansen H.H., and Petersen G. N-acylethanolamines and precursor phospholipids - relation to cell injury. Chem. Phys. Lipids 108 (2000) 135-150
99. Hill M.M., Clark S.F., Tucker D.F., Birnbaum M.J., James D.E., and Macaulay S.L. A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell. Biol. 19 (1999) 7771-7781
100. Hillard C.J., and Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids 108 (2000) 123-134
101. Hinz B., and Hirschelmann R. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm. Res. 17 (2000) 1273-1277
102. Hirasawa M., Schwab Y., Natah S., Hillard C.J., Mackie K., Sharkey K.A., and Pittman Q.J. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J. Physiol. 559 (2004) 611-624
103. Ho W.S., and Randall M.D. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br. J. Pharmacol. 150 (2007) 641-651
104. Horrocks L.A. Sources for brain arachidonic acid uptake and turnover in glycerophospholipids. Ann. N. Y. Acad. Sci. 559 (1989) 17-24
105. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 607-634
106. Howlett A.C. Cannabinoid receptor signaling. Handb. Exp. Pharmacol. (2005) 53-79
107. Htun H., Barsony J., Renyi I., Gould D.L., and Hager G.L. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4845-4850
108. Huang S.M., Bisogno T., Petros T.J., Chang S.Y., Zavitsanos P.A., Zipkin R.E., Sivakumar R., Coop A., Maeda D.Y., De Petrocellis L., Burstein S., Di Marzo V., and Walker J.M. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 276 (2001) 42639-42644
109. Hyde G.N., Seale A.P., Grau E.G., and Borski R.J. Cortisol rapidly suppresses intracellular calcium and voltage-gated calcium channel activity in prolactin cells of the tilapia (Oreochromis mossambicus). Am. J. Physiol. Endocrinol. Metab. 286 (2004) E626-E633
110. Inagaki N., Miura T., Nakajima T., Yoshida K., Nagai H., and Koda A. Studies on the anti-allergic mechanism of glucocorticoids in mice. J. Pharmacobiodyn. 15 (1992) 581-587
111. Inoue W., Poole S., Bristow A.F., and Luheshi G.N. Leptin induces cyclooxygenase-2 via an interaction with interleukin-1beta in the rat brain. Eur. J. Neurosci. 24 (2006) 2233-2245
112. Iversen L., and Kragballe K. Arachidonic acid metabolism in skin health and disease. Prostaglandins Other Lipid Mediat. 63 (2000) 25-42
113. Janeway Jr. C.A., and Bottomly K. Signals and signs for lymphocyte responses. Cell 76 (1994) 275-285
114. Jewell C.M., Webster J.C., Burnstein K.L., Sar M., Bodwell J.E., and Cidlowski J.A. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 55 (1995) 135-146
115. Jingami H., Matsukura S., Numa S., and Imura H. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 117 (1985) 1314-1320
116. Joels M., and De Kloet E.R. Coordinative mineralocorticoid and glucocorticoid receptor-mediated control of responses to serotonin in rat hippocampus. Neuroendocrinology 55 (1992) 344-350
117. Kasai M., Kannan H., Ueta Y., Osaka T., Inenaga K., and Yamashita H. Effects of iontophoretically applied cortisol on tuberoinfundibular neurons in hypothalamic paraventricular nucleus of anesthetized rats. Neurosci. Lett. 87 (1988) 35-40
118. Kasai M., and Yamashita H. Inhibition by cortisol of neurons in the paraventricular nucleus of the hypothalamus in adrenalectomized rats; an in vitro study. Neurosci. Lett. 91 (1988) 59-64
119. Keller-Wood M., Leeman E., Shinsako J., and Dallman M.F. Steroid inhibition of canine ACTH: in vivo evidence for feedback at the corticotrope. Am. J. Physiol. 255 (1988) E241-E246
120. Keller-Wood M.E., and Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5 (1984) 1-24
121. Kim J., and Alger B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7 (2004) 697-698
122. Kondo S., Sugiura T., Kodaka T., Kudo N., Waku K., and Tokumura A. Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. Arch. Biochem. Biophys. 354 (1998) 303-310
123. Kozak K.R., Crews B.C., Morrow J.D., Wang L.H., Ma Y.H., Weinander R., Jakobsson P.J., and Marnett L.J. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 277 (2002) 44877-44885
124. Kozak K.R., and Marnett L.J. Oxidative metabolism of endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 211-220
125. Kozak K.R., Rowlinson S.W., and Marnett L.J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J. Biol. Chem. 275 (2000) 33744-33749
126. Kreitzer A.C., and Regehr W.G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J. Neurosci. 21 (2001) RC174
127. Kreitzer A.C., and Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29 (2001) 717-727
128. Kruszka K.K., and Gross R.W. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor. J. Biol. Chem. 269 (1994) 14345-14348
129. Lambert D.M., Vandevoorde S., Jonsson K.O., and Fowler C.J. The palmitoylethanolamide family: a new class of anti-inflammatory agents?. Curr. Med. Chem. 9 (2002) 663-674
130. 2 by melittin. Arch. Biochem. Biophys. 389 (2001) 57-67
131. Lepine S., Lakatos B., Courageot M.P., Le Stunff H., Sulpice J.C., and Giraud F. Sphingosine contributes to glucocorticoid-induced apoptosis of thymocytes independently of the mitochondrial pathway. J. Immunol. 173 (2004) 3783-3790
132. Li Q.J., Dinner A.R., Qi S., Irvine D.J., Huppa J.B., Davis M.M., and Chakraborty A.K. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat. Immunol. 5 (2004) 791-799
133. 2 is phosphorylated and activated by MAP kinase. Cell 72 (1993) 269-278
134. Liu J., Batkai S., Pacher P., Harvey-White J., Wagner J.A., Cravatt B.F., Gao B., and Kunos G. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J. Biol. Chem. 278 (2003) 45034-45039
135. Lowenberg M., Tuynman J., Bilderbeek J., Gaber T., Buttgereit F., van Deventer S., Peppelenbosch M., and Hommes D. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 106 (2005) 1703-1710
136. Lowenberg M., Tuynman J., Scheffer M., Verhaar A., Vermeulen L., van Deventer S., Hommes D., and Peppelenbosch M. Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling. Endocrinology 147 (2006) 3555-3562
137. Lowenberg M., Verhaar A.P., Bilderbeek J., Marle J., Buttgereit F., Peppelenbosch M.P., van Deventer S.J., and Hommes D.W. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep. 7 (2006) 1023-1029
138. Luconi M., Francavilla F., Porazzi I., Macerola B., Forti G., and Baldi E. Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids 69 (2004) 553-559
139. Lustgarten J., Waks T., and Eshhar Z. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex. Eur. J. Immunol. 21 (1991) 2507-2515
140. Maccarrone M., Bari M., Lorenzon T., Bisogno T., Di Marzo V., and Finazzi-Agro A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem. 275 (2000) 13484-13492
141. Maejima T., Ohno-Shosaku T., and Kano M. Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals. Neurosci. Res. 40 (2001) 205-210
142. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., and Tasker J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J. Neurosci. 26 (2006) 6643-6650
143. Marchetti M.C., Di Marco B., Cifone G., Migliorati G., and Riccardi C. Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101 (2003) 585-593
144. McEwen B.S., De Kloet E.R., and Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66 (1986) 1121-1188
145. McGiff J.C. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31 (1991) 339-369
146. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
147. Mechoulam R., Fride E., and Di Marzo V. Endocannabinoids. Eur. J. Pharmacol. 359 (1998) 1-18
148. Mitchell J.A., Belvisi M.G., Akarasereenont P., Robbins R.A., Kwon O.J., Croxtall J., Barnes P.J., and Vane J.R. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br. J. Pharmacol. 113 (1994) 1008-1014
149. Moldrich G., and Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21 (2000) 1735-1742
150. Mollay C., Kreil G., and Berger H. Action of phospholipases on the cytoplasmic membrane of Escherichia coli. Stimulation by melittin. Biochim. Biophys. Acta 426 (1976) 317-324
151. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
152. Mustelin T., and Tasken K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371 (2003) 15-27
153. Natarajan V., Schmid P.C., Reddy P.V., and Schmid H.H. Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J. Neurochem. 42 (1984) 1613-1619
154. Nel A.E. T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J. Allergy Clin. Immunol. 109 (2002) 758-770
155. Nel A.E., and Slaughter N. T-cell activation through the antigen receptor. Part 2: role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy. J. Allergy Clin. Immunol. 109 (2002) 901-915
156. Newton R., Seybold J., Kuitert L.M., Bergmann M., and Barnes P.J. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J. Biol. Chem. 273 (1998) 32312-32321
157. Nordeen S.K., Bona B.J., Beck C.A., Edwards D.P., Borror K.C., and DeFranco D.B. The two faces of a steroid antagonist: when an antagonist isn't. Steroids 60 (1995) 97-104
158. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., and Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci. 22 (2002) 3864-3872
159. Okamoto Y., Morishita J., Tsuboi K., Tonai T., and Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279 (2004) 5298-5305
160. Pagotto U., Marsicano G., Fezza F., Theodoropoulou M., Grubler Y., Stalla J., Arzberger T., Milone A., Losa M., Di Marzo V., Lutz B., and Stalla G.K. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J. Clin. Endocrinol. Metab. 86 (2001) 2687-2696
161. Palacios E.H., and Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23 (2004) 7990-8000
162. Paria B.C., Deutsch D.D., and Dey S.K. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol. Reprod. Dev. 45 (1996) 183-192
163. Pariante C.M., Pearce B.D., Pisell T.L., Su C., and Miller A.H. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells. J. Endocrinol. 169 (2001) 309-320
164. Payne L.C., Weigent D.A., and Blalock J.E. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 198 (1994) 480-484
165. Picard D., and Yamamoto K.R. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. Embo. J. 6 (1987) 3333-3340
166. Picotto G., Massheimer V., and Boland R. Acute stimulation of intestinal cell calcium influx induced by 17 beta-estradiol via the cAMP messenger system. Mol. Cell. Endocrinol. 119 (1996) 129-134
167. Piomelli D., Beltramo M., Glasnapp S., Lin S.Y., Goutopoulos A., Xie X.Q., and Makriyannis A. Structural determinants for recognition and translocation by the anandamide transporter. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5802-5807
168. Pitler T.A., and Alger B.E. Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J. Neurosci. 12 (1992) 4122-4132
169. Pompeo A., Luini A., and Buccione R. Functional dissociation between glucocorticoid-induced decrease in arachidonic acid release and inhibition of adrenocorticotropic hormone secretion in AtT-20 corticotrophs. J. Steroid Biochem. Mol. Biol. 60 (1997) 51-57
170. Pratt W.B. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med. 217 (1998) 420-434
171. Prescott S.M., and Majerus P.W. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J. Biol. Chem. 258 (1983) 764-769
172. Proud C.G., and Denton R.M. Molecular mechanisms for the control of translation by insulin. Biochem. J. 328 Pt 2 (1997) 329-341
173. Qi M., Stasenko L.J., and DeFranco D.B. Recycling and desensitization of glucocorticoid receptors in v-mos transformed cells depend on the ability of nuclear receptors to modulate gene expression. Mol. Endocrinol. 4 (1990) 455-464
174. 2, C and D in the presence of membrane active peptides. Biochem. Biophys. Res. Commun. 182 (1992) 682-688
175. Ristimaki A., Narko K., and Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem. J. 318 Pt 1 (1996) 325-331
176. Rivas A., Takada S., Koide J., Sonderstrup-McDevitt G., and Engleman E.G. CD4 molecules are associated with the antigen receptor complex on activated but not resting T cells. J. Immunol. 140 (1988) 2912-2918
177. Robbe D., Alonso G., Duchamp F., Bockaert J., and Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21 (2001) 109-116
178. Rouzer C.A., and Marnett L.J. Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus. J. Biol. Chem. 280 (2005) 26690-26700
179. Rudd C.E., Anderson P., Morimoto C., Streuli M., and Schlossman S.F. Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation. Immunol. Rev. 111 (1989) 225-266
180. Rupprecht R., Reul J.M., van Steensel B., Spengler D., Soder M., Berning B., Holsboer F., and Damm K. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 247 (1993) 145-154
181. Sackey F.N., Watson C.S., and Gametchu B. Cell cycle regulation of membrane glucocorticoid receptor in CCRF-CEM human ALL cells: correlation to apoptosis. Am. J. Physiol. 273 (1997) E571-E583
182. Salojin K.V., Zhang J., and Delovitch T.L. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J. Immunol. 163 (1999) 844-853
183. Sang N., and Chen C. Lipid signaling and synaptic plasticity. Neuroscientist 12 (2006) 425-434
184. 2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. J. Physiol. 572 (2006) 735-745
185. Saphier D., and Feldman S. Iontophoretic application of glucocorticoids inhibits identified neurones in the rat paraventricular nucleus. Brain Res. 453 (1988) 183-190
186. Schmid H.H. Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?. Chem. Phys. Lipids 108 (2000) 71-87
187. Schmid H.H., and Berdyshev E.V. Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 363-376
188. Schmid H.H., Schmid P.C., and Natarajan V. N-acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29 (1990) 1-43
189. Schmid P.C., Krebsbach R.J., Perry S.R., Dettmer T.M., Maasson J.L., and Schmid H.H. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375 (1995) 117-120
190. Schmidt B.M., Gerdes D., Feuring M., Falkenstein E., Christ M., and Wehling M. Rapid, nongenomic steroid actions: a new age?. Front. Neuroendocrinol. 21 (2000) 57-94
191. Schmidt T.J. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486. J. Steroid Biochem. 24 (1986) 853-863
192. Seeds M.C., and Bass D.A. Regulation and metabolism of arachidonic acid. Clin. Rev. Allergy Immunol. 17 (1999) 5-26
193. Sharkey K.A., Cristino L., Oland L.D., Van Sickle M.D., Starowicz K., Pittman Q.J., Guglielmotti V., Davison J.S., and Di Marzo V. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur. J. Neurosci. 25 (2007) 2773-2782
194. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
195. 2 activating protein (PLAP) and melittin. Biochim. Biophys. Acta 1166 (1993) 124-130
196. Stella N., Schweitzer P., and Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-778
197. Stellato C. Post-transcriptional and nongenomic effects of glucocorticoids. Proc. Am. Thorac. Soc. 1 (2004) 255-263
198. Sugiura T., Kobayashi Y., Oka S., and Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fat. Acids 66 (2002) 173-192
199. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215 (1995) 89-97
200. Sugiura T., Oka S., Gokoh M., Kishimoto S., and Waku K. New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. J. Pharmacol. Sci. 96 (2004) 367-375
201. 2 and lysophospholipase D. Biochem. J. 380 (2004) 749-756
202. 2 in induction of tissue plasminogen activator (t-PA) production by human fibroblast, IMR-90 cells, stimulated by proteose peptone. Thromb. Res. 64 (1991) 191-202
203. Tanaka H., Watanabe K., Tamaru N., and Yoshida M. Arachidonic acid metabolites and glucocorticoid regulatory mechanism in cultured porcine tracheal smooth muscle cells. Lung 173 (1995) 347-361
204. Tempel D.L., Kim T., and Leibowitz S.F. The paraventricular nucleus is uniquely responsive to the feeding stimulatory effects of steroid hormones. Brain Res. 614 (1993) 197-204
205. Tiwari S., Dong H., Kim E.J., Weintraub L., Epstein P.M., and Lerner A. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation. Biochem. Pharmacol. 69 (2005) 473-483
206. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
207. Tsutsumi T., Kobayashi T., Miyashita M., Watanabe S., Homma Y., and Okuyama H. A lysophosphoinositide-specific phospholipase C distinct from other phospholipase C families in rat brain. Arch. Biochem. Biophys. 317 (1995) 331-336
208. Tsutsumi T., Kobayashi T., Ueda H., Yamauchi E., Watanabe S., and Okuyama H. Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes. Neurochem. Res. 19 (1994) 399-406
209. Turnbow M.A., Keller S.R., Rice K.M., and Garner C.W. Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L1 adipocytes. J. Biol. Chem. 269 (1994) 2516-2520
210. Ueda H., Kobayashi T., Kishimoto M., Tsutsumi T., and Okuyama H. A possible pathway of phosphoinositide metabolism through EDTA-insensitive phospholipase A1 followed by lysophosphoinositide-specific phospholipase C in rat brain. J. Neurochem. 61 (1993) 1874-1881
211. Ueda N., Kurahashi Y., Yamamoto K., and Yamamoto S. Anandamide amidohydrolase from porcine brain. Partial purification and characterization. Adv. Exp. Med. Biol. 407 (1997) 323-328
212. Ueda N., Kurahashi Y., Yamamoto S., and Tokunaga T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270 (1995) 23823-23827
213. Ullrich O., Schneider-Stock R., and Zipp F. Cell-cell communication by endocannabinoids during immune surveillance of the central nervous system. Results Probl. Cell. Differ 43 (2006) 281-305
214. Urbach V., and Harvey B.J. Rapid and non-genomic reduction of intracellular [Ca(2+)] induced by aldosterone in human bronchial epithelium. J. Physiol. 537 (2001) 267-275
215. Urbach V., Verriere V., Grumbach Y., Bousquet J., and Harvey B.J. Rapid anti-secretory effects of glucocorticoids in human airway epithelium. Steroids 71 (2006) 323-328
216. - secretion by dexamethasone in human bronchial epithelium. J. Physiol. 545 (2002) 869-878
217. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
218. Varga K., Wagner J.A., Bridgen D.T., and Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 12 (1998) 1035-1044
219. Verriere V.A., Hynes D., Faherty S., Devaney J., Bousquet J., Harvey B.J., and Urbach V. Rapid effects of dexamethasone on intracellular pH and Na+/H+ exchanger activity in human bronchial epithelial cells. J. Biol. Chem. 280 (2005) 35807-35814
220. Verty A.N., McGregor I.S., and Mallet P.E. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology 49 (2005) 1101-1109
221. Wahn H., Wolf J., Kram F., Frantz S., and Wagner J.A. The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H2491-H2496
222. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., and Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19 (1999) 4008-4018
223. Weber A., Ni J., Ling K.H., Acheampong A., Tang-Liu D.D., Burk R., Cravatt B.F., and Woodward D. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. J. Lipid Res. 45 (2004) 757-763
224. Wenger T., Jamali K.A., Juaneda C., Leonardelli J., and Tramu G. Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. Biochem. Biophys. Res. Commun. 237 (1997) 724-728
225. Wenger T., Ledent C., and Tramu G. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice. Neuroendocrinology 78 (2003) 294-300
226. White M.F. The insulin signalling system and the IRS proteins. Diabetologia 40 Suppl. 2 (1997) S2-S17
227. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592
228. Wittmann G., Deli L., Kallo I., Hrabovszky E., Watanabe M., Liposits Z., and Fekete C. Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus. J. Comp. Neurol. 503 (2007) 270-279
229. Woods M.D., Shipston M.J., Mullens E.L., and Antoni F.A. Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids. Endocrinology 131 (1992) 2873-2880
230. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim. Biophys. Acta 1128 (1992) 117-131
231. Yang H., Wang L., and Ju G. Evidence for hypothalamic paraventricular nucleus as an integrative center of neuroimmunomodulation. Neuroimmunomodulation 4 (1997) 127
232. Yu M., Ives D., and Ramesha C.S. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem. 272 (1997) 21181-21186
233. 2 and phospholipase C signal-transduction pathways. Life Sci. 48 (1991) 2089-2095